Explore

Companies

Drugs

About·Data Management·Terms·Privacy

Stay informed

© 2026 VivoSeq. All rights reserved.

Motivation-Phase Nicotine Mini-Lozenge

Approved

VVA Office of Research and Development

1

Indications

1

Total Trials

1

Active Trials

0

Competitors

Pipeline

Status by Indication[2][1]

Indication

VeteransNot yet recruiting

VeteransApproved

Not yet recruiting

Timeline

Expected Milestones

Q2 2030

ApprovedNot yet recruiting

Veterans

NCT06966362

Clinical

Trials by Indication[1]

Veterans1 trial

Varenicline for Smoking Reduction in Veterans Unwilling to Quit

Not yet recruiting·VVA Office of Research and Development·Approved·NCT06966362·400 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for Motivation-Phase Nicotine Mini-Lozenge. U.S. National Library of Medicine, National Institutes of Health.
[2]
Open Targets Platform — Drug–disease associations for Motivation-Phase Nicotine Mini-Lozenge. EMBL-EBI & Wellcome Sanger Institute.
[3]
SEC EDGAR — VA Office of Research and Development company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Highest Phase: Approved[1]
Company: VVA Office of Research and Development

Related News